Puretech Health plc (PRTC) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
London close: Stocks weaker ahead of key central bank decisions
16 December 2024 15:35
(Sharecast News) - London stocks ended lower on Monday as investors adopted a cautious stance ahead of a week filled with major central bank policy decisions.
-
PureTech hails "exciting" results from lung disease trial
16 December 2024 09:30
(Sharecast News) - Clinical-stage biotech group Puretech Health has announced promising results from the trial of its lung disease treatment deupirfenidone, which the lead investigator hailed as...
-
London close: Stocks give up gains to finish in the red
21 October 2024 15:48
(Sharecast News) - London stocks ended lower on Monday, after the People's Bank of China made bigger-than-expected cuts to loan prime rates, while UK house price growth stagnated.
-
PureTech's Seaport closes $225m series B round
21 October 2024 12:45
(Sharecast News) - PureTech Health announced on Monday that Seaport Therapeutics, a company it founded, has closed an oversubscribed $225m series B financing round.
-
London close: Stocks rise as US PCE inflation slows
27 September 2024 16:58
(Sharecast News) - London stocks closed higher on Friday as investors digested a slowdown in the Federal Reserve's preferred inflation measure.
-
PureTech receives $29m royalty from Karuna schizophrenia treatment
27 September 2024 07:17
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health has announced that the schizophrenia treatment it developed, which was later sold to Bristol Myers Squibb, has been approved by US...
-
PureTech Health launches $100m tender offer
20 May 2024 10:13
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American...
-
Puretech Health operating losses narrow in 'landmark year'
25 April 2024 10:07
(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic and clinical progress".
-
PureTech founder steps down as CEO to lead SeaPort spin-off
9 April 2024 07:48
(Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just...
-
Puretech Health proposes $100m capital return
19 March 2024 09:46
(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.
-
US Royalty Pharma strikes deal with PureTech Health on KarXT royalties
23 March 2023 07:24
(Sharecast News) - US-listed Royalty Pharma has acquired an interest in PureTech Health's royalty in Karuna Therapeutics' KarXT drug for up to $500m, with $100m in cash up front and up to $400m in...
-
PureTech's Alkili reports success in adolescent ADHD study
6 January 2023 18:31
(Sharecast News) - Clinical-stage biotherapeutics investor PureTech Health announced on Friday today that its digital medicine company Akili, which it founded, announced topline results of the...
Company announcements Announcements
-
PRTC's Ph2b in IPF Successful; New SOC Potential
16 December 2024 07:00
PureTech Health
-
Holding(s) in Company
11 December 2024 17:30
PureTech Health
-
PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP
11 December 2024 12:05
PureTech Health
-
PRTC Presents LYT-200 Phase 1b Data in AML at ASH
9 December 2024 07:00
PureTech Health
-
Holding(s) in Company
27 November 2024 17:31
PureTech Health
-
Holding(s) in Company
27 November 2024 17:30
PureTech Health
-
PRTC's Seaport Adds Microsoft and J&J Exec to BOD
20 November 2024 12:05
PureTech Health
-
Total Voting Rights
1 November 2024 07:00
PureTech Health
-
Director/PDMR Shareholding
31 October 2024 17:00
PureTech Health
-
PRTC's Seaport Closes $225M Series B Financing
21 October 2024 07:00
PureTech Health
-
KarXT/Cobenfy Approved by FDA; PRTC Receives $29M
27 September 2024 07:00
PureTech Health
-
Holding(s) in Company
6 September 2024 18:13
PureTech Health
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.